---
title: "Nanjing Huamai Technology and related responsible persons received a warning letter from Jiangsu Securities Regulatory Bureau"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/246407057.md"
description: "Nanjing Huamai Technology recently received a warning letter from the Jiangsu Securities Regulatory Bureau for failing to timely review related party transactions for the year 2025 and related years, with some transaction amounts exceeding the review limit. In addition, the company's guarantee amount for its controlling subsidiary exceeded the review limit, and it did not disclose significant guarantee progress. The company was not prudent in decision-making regarding fundraising projects, and the risk disclosure regarding the use of raised funds was insufficient, with some instances of non-compliant usage"
datetime: "2025-06-27T11:12:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/246407057.md)
  - [en](https://longbridge.com/en/news/246407057.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/246407057.md)
---

# Nanjing Huamai Technology and related responsible persons received a warning letter from Jiangsu Securities Regulatory Bureau

According to the announcement from Zhitong Finance APP, Nanjing Huamai Technology Co., Ltd. (603042.SH) has received a decision from the Jiangsu Regulatory Bureau of the China Securities Regulatory Commission regarding the issuance of a warning letter to Nanjing Huamai Technology Co., Ltd. and related responsible persons (\[2025\] No. 89).

After investigation, the company has the following issues: First, the company did not timely review related party transactions for the first three months of 2025 and related years, holding a board meeting for supplementary review only in March or April of that year; at the same time, some related party transaction amounts for 2024 exceeded the review limit. Second, the company provided guarantees for its controlling subsidiaries that exceeded the review limit and did not disclose significant guarantee progress for that controlling subsidiary. Third, the company was not prudent in decision-making for some fundraising projects, and the risk disclosure regarding the reasons for not meeting the planned progress of previous years' fundraising was insufficient, while there were also minor instances of non-compliance in the use of raised funds

### Related Stocks

- [603042.CN](https://longbridge.com/en/quote/603042.CN.md)

## Related News & Research

- [PharmEasy's parent has a new playbook: Profit first, growth second](https://longbridge.com/en/news/286890424.md)
- [India's lifeline ferry across strategic archipelago](https://longbridge.com/en/news/286716580.md)
- [Possible Bearish Signals With Remgro Insiders Disposing Stock](https://longbridge.com/en/news/287005043.md)
- [Cagent Vascular closes oversubscribed $41 million Series D financing round](https://longbridge.com/en/news/287114819.md)
- [Ottawa Bancorp declares quarterly cash dividend of $0.11 per share](https://longbridge.com/en/news/287112130.md)